Webinar Highlights
This on-demand session provides a foundational overview of IHC, starting from its preclinical applications and extending to its pivotal role in early clinical trials. Our expert speakers, Amanda Woodrooffe, PhD, providing a scientific perspective, and Dawn Butler, MD, offering insights from a pathologist's viewpoint, guide you through the essential aspects of IHC, including its importance in biomarker validation and the transition from preclinical assay development to early clinical application.In this webinar, we discuss in detail the complex process of antibody selection, covering both commercial and proprietary types. You'll learn about the benefits of using IHC for target and biomarker validation, and understand its multifaceted applications in disease screening and decision-making for treatment.Key Takeaways:
- Fundamentals of IHC and its role in preclinical and early clinical trials.
- Detailed exploration of the IHC biomarker identification and validation processes.
- Guidance on transitioning IHC assays from research to early clinical practice.
- How IHC compares to other tissue profiling technologies including PCR, NGS, and multiplex immunofluorescence.
- The importance of antibody selection, guidance on selection criteria for antibodies, and how to apply this in assay development.
Don't miss this opportunity to enhance your knowledge and leverage IHC to its fullest potential in both research and early clinical settings. Register now!To watch the second installment of the webinar series, click here to register.
Presenters
Amanda Woodrooffe
Amanda Woodrooffe, PhD, is the General Manager of UK Labs at Precision for Medicine. She brings years of experience as a leader of scientific operations and excels as a collaborative partner. She focuses on methods and approaches to provide actionable data which can directly enable biopharmaceutical research and development.
Dawn Butler
Dr. Butler, a triple-board certified pathologist specializing in hematopathology, has a clinical diagnostic medicine background. She has six years of experience in IHC validation with the industry. Currently, she collaborates with clients to validate immunohistochemistry for clinical trial patient enrollment.
Sponsor
Precision for Medicine
Content Partners
Scientist.com
Scientist.com is the world’s largest and first platform built for the intricacies of scientific outsourcing.
We help pharmaceutical and biotechnology organizations discover, engage, manage, and scale relationships with the providers that support every stage of the pipeline—from discovery and preclinical research to clinical development, manufacturing, medical affairs, and commercialization. Through a centralized platform, organizations can access a global network of 6,000+ providers, streamline sourcing and procurement workflows, maintain compliance, manage supplier relationships, and leverage data-driven insights to make faster, more informed decisions.
Today, Scientist.com supports more than 130 life science organizations, including 24 of the world's top 30 pharmaceutical companies, helping teams reduce operational complexity, accelerate timelines, and bring innovations to patients faster. Our mission is to make it possible to cure all human disease by 2050.
